Trabecular oedema
medical condition
Trabecular edema, also known as bone marrow edema (BME), is a traditional term describing the interstitial fluid accumulation at the trabecular bone marrow. The term was first used in 1988, referring to the changes in the bone marrow due to inflammation. Bone marrow edema was later renamed to bone marrow lesion (BML), as later studies show that the increased fluid content in the trabecular bone was more likely caused by inflammatory responses (e.g. increased vascularization, lymphocyte infiltration) instead of fluid influx (i.e. edema). Hence, this narrows down the condition to the damage at the articular surface of the trabecular bones. Despite so, the terms BME and BML are still used interchangeably in radiology.
This condition normally affects the musculoskeletal system, and commonly manifests in lower extremities, including but not limited to the feet, ankle joints, knee joints, and hip joints. Common signs and symptoms include pain, joint swelling, and limited joint functionality. BME can be further separated into two types, based on their causes: primary BME and secondary BME. Primary BME, also called spontaneous BME or bone marrow edema syndrome (BMES), means bone marrow edema without obvious causes.
The public source identifies “Trabecular oedema” as medical condition. This brief keeps that definition visible, then builds a research path around Trabecular, oedema and medical.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Trabecular oedema”, the useful work is to connect “medical condition” to the records capable of establishing context and consequence.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jun 8, 2026. The linked authority identifier is Q120962773. The first chronological checks are 1988.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Trabecular oedema”, its source revision and the description used here.
- Expand the search: follow Trabecular oedema primary sources, Trabecular oedema archive and Trabecular research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Trabecular oedema”?
- What terminology or title could unlock a more precise catalogue search?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Trabecular oedema” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.